External Innovation

From fundamental research to clinical development, the in-house efforts made by Ipsen’s R&D department are supported by an active partnerships policy.

 
We make sure we access the best information and opportunities provided through external networks, and maximize the potential for in-licensing novel and life-changing treatments. The partnerships that we develop with leading academic institutes, biotechs and medical centers allow us to test the relevance of our research concepts.

Our philosophy in this respect is based on the knowledge that even though Ipsen’s R&D employees are leading experts in their fields, they represent only a tiny fraction of the expertise available in our specialist fields around the world. It is therefore essential to combine internal skills and projects with those of other leading actors in medical and pharmaceutical R&D.

Last update 13/10/2017